News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nuheara.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Cochlear can weather the coronavirus-induced China slump
Health & Biotech
Health: Somnomed spins fairytale of a sleep cure in half-year results
Health & Biotech
Health: UBI has more cash than its market cap
Tech
Tech: The only ASX small cap in food delivery has gone from processing thousands to millions of orders
News
The picks and flicks of today’s ASX small cap quarterlies & financial outlooks
News
Short & Caught: The small caps investors are shorting right now
Health & Biotech
Health: Human cell proteins + cannabis = fountain of youth?
Health & Biotech
Health: Immuron takes a dive after drug fails in alcoholic hepatitis trial
Health & Biotech
Health: PainChek wants to know if its app can detect pain in babies
Health & Biotech
Health: Hear that? Nuheara is in play after someone tried to take it over
News
It’s not just Labor’s franking credit threat that’s already sending investors to America
Health & Biotech
Health: G Medical is close to listing on the NASDAQ and Hong Kong exchanges
News
Rise and Shine: What you need to know before the ASX opens
Tech
Nuheara spruiks strong sales but auditors are concerned about its future
Director trades: All the action is under the radar
Tech
